ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of Hepatitis B and Hepatitis C in Taiwan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00946010
Recruitment Status : Completed
First Posted : July 24, 2009
Last Update Posted : January 24, 2011
Sponsor:
Information provided by:
National Taiwan University Hospital

Brief Summary:
The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Condition or disease Intervention/treatment
Hepatitis B Hepatitis C Biological: blood sampling and abdominal sonography

Detailed Description:
The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.

Study Type : Observational
Actual Enrollment : 6228 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Investigation of Hepatitis B and Hepatitis C in Taiwan
Study Start Date : April 2008
Actual Primary Completion Date : August 2010
Actual Study Completion Date : January 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
1
Click here for more information about this study: Investigation of Hepatitis B and Hepatitis C in Taiwan
Biological: blood sampling and abdominal sonography
10cc blood sampling and abdominal sonography
Other Name: 10cc blood sampling and abdominal sonography



Primary Outcome Measures :
  1. genotype and DNA level or RNA level of HBV and HCV virus [ Time Frame: once during Mar. 2008- Jan. 2011 ]

Biospecimen Retention:   Samples With DNA
10ml blood was sampled and then serum was be retained.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   23 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
People Born before 1985/01/01 who live in Taiwan are HBV or HCV pateints.
Criteria

Inclusion Criteria:

  • Born before 1985/01/01
  • HBV or HCV carriers

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00946010


Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Study Chair: Jin-Chuan Sheu, M.D. P.H.D. National Taiwan University Hospital

Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00946010     History of Changes
Other Study ID Numbers: 200801059R
First Posted: July 24, 2009    Key Record Dates
Last Update Posted: January 24, 2011
Last Verified: January 2011

Keywords provided by National Taiwan University Hospital:
Hepatitis B
Hepatitis C
genotype
DNA level
RNA level
Taiwan

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis C
Hepatitis B
Hepatitis, Viral, Human
Liver Diseases
Digestive System Diseases
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections
Hepadnaviridae Infections
DNA Virus Infections